Miltonia Health Science was founded in year 2009. Our employees are professionals with many years of professional experience in multinational pharmaceutical corporations. The company was founded with a focus of fulfilling all the knowledge which was obtained during the years of work to develop better drugs for improving the quality and comfort of patients.

Miltonia Health Science develops and produces its own branded medicines and medical devices through third party manufacturing agreements and also in-licenses brands for marketing from other Pharmaceutical manufacturers.

We cooperate with manufacturers that produce products for large pharmaceutical companies around the world.

The company's products are sold in 22 countries:

- CIS: Moldova, Georgia, Armenia, Turkmenistan, Uzbekistan,
Kyrgyzstan, Tajikistan, Mongolia.

- West Africa region: – Benin, Burkina Faso, Cameroon,
Congo, Cote d’Ivoire, Gabon, Guinee, Mauritanie, Niger, Senegal, Togo, Republic of Rwanda, Burundi.

Continuous development, adherence to high standards and achievement of outstanding results are the three whales on which our professionalism rests.
customer orientation
We are attentive to the needs of our customers, reacting quickly to their objections, which allows us to keep the quality of products at a high level.
long-term relationship
We are focused only on long-term and trusting relations with our Clients and Partners.
  • 2009
  • 12th June - Company Registration in UK. Signed contracts with Softgel healthcare ltd & Elder Pharma for Developing MHS own brand VAGIMILT, MUCOMILT, FLAVOVEIN.

  • 2010
  • Official opening of Miltonia Health Science Representative office in Kiev, Ukraine. Signed in-licensing contract for BICYCLOL with Beijing Union pharmaceutical factory - China. Registration of BICYCLOL & VAGIMILT in Uzbekistan.

  • 2010
  • 2011
  • Registration of FLAVOVEIN in Uzbekistan, while VAGIMILT and BICYCLOL are already on the market. Registration of BICYCLOL and VAGIMILT in Kyrgyzstan.

  • 2012
  • Launch of VAGIMILT and BICYCLOL on market of Kyrgyzstan and Tajikistan. Registration of VAGIMILT and BICYCLOL in Georgia. Registration of VAGIMILT in Guinea and Gabon (Africa). Registration of tabs and syrup MUCOMILT in Uzbekistan and Kyrgyzstan.

  • 2012
  • 2013
  • Launch of VAGIMILT and BICYCLOL in Georgia.

    Registration of tabs and syrup MUCOMILT in Tajikistan.

  • 2014
  • Registration of VAGIMILT in Côte d'Ivoire, Cameroon, Togo, its launch in the French-speaking region of Africa. Registration of VAGIMILT, FLAVOVEIN and MUCOMILT in Turkmenistan.

    Registration of FLAVOVEIN and VAGIMILT in Moldova.

    Signed a contract with Unique Biotech (India) for manufacturing of VAGIPROBIOX.

  • 2014
  • 2015
  • Registration and re-registration in following countries:

    Uzbekistan: re-registration of VAGIMILT and BICYCLOL.

    Tajikistan: registration of VAGIPROBIOX.

    Georgia: registration of FLAVOVEIN and VAGIPROBIOX.

    Turkmenistan: registration of VAGIPROBIOX.

    Mongolia and Senegal: registration of VAGIMILT.

  • 2016
  • Registration of two doses of CANDIMILT in Tajikistan and Turkmenistan.

    Start VAGIMILT sales in Mongolia.

    Preparing for registration of new product FEMIGESTON. Bio-equivalence study drug.

    Our experts modified the composition of VAGIMILT and introduced a new sub-component Dimethicone + MCT, to improve the tolerability.

    Preparing for registration of new product MILPLAST in Ukraine.

  • 2016
  • 2017
  • Launch of own brand of plasters MILPLAST in Ukraine

  • 2018
  • Registration of VAGIMILT in Algeria.

    Launch of VAGIMILT in RDC & Burundi.

    Re-registration of VAGIMILT in Guinea & Gabon.

    Registration of FEMIGESTON in Benin, Burkina Faso, Congo, Gabon, Guinea.

  • 2018

All MILPLAST patches are manufactured in Europe (Italy, Spain) using advanced technologies and high-quality materials. MILPLAST patches meet the basic requirements and standards of the European Union and undergo the most stringent quality control and a full procedure for assessing compliance with the directives - as evidenced by the EU mark on the packaging.